European Multidisciplinary Conference in Thoracic Oncology

December 21, 2010

The number of diagnostic and therapeutic options for patients with thoracic malignancies has markedly increased, allowing for an individualized approach based on the clinical situation and molecular characteristics of the tumor. How to best select among these options for the benefit of the patients within an integrative treatment approach will be at the core of the conference.

"The number of diagnostic and therapeutic options for patients with thoracic malignancies has markedly increased, allowing for an individualized approach based on the clinical situation and molecular characteristics of the tumor. How to best select among these options for the benefit of the patients within an integrative treatment approach will be at the core of the conference"

Rolf Stahel, EMCTO 2011 Chair

Despite the fact that chest tumors are difficult to treat, major advances have been made in areas such as the testing of EGFR mutations, the use of targeted therapies in advanced non-small cell lung cancer and the establishment of adjuvant chemotherapy in completely resected NSCLC or prophylactic cranial irradiation in small-cell lung cancer, and improvements in radiotherapy and surgery techniques.

As a multidisciplinary, educational conference, EMCTO will provide an update on recent advances in the prevention, biology, diagnosis, staging and treatment of thoracic malignancies.

Experts of the various disciplines will discuss these advances and provide a multidisciplinary overview and update of the current state-of-the-art management of patients with thoracic malignancies.

The conference full program is available at http://www.esmo.org/events/lung-2011-emcto/program.html

Please contact the EMCTO Press Office immediately at media@esmo.org to book a telephone hook-up, to schedule your remote interviews or register for the event.

All sessions are open to journalists and registration is free to bona fide journalists on presentation of a valid press card and a letter of assignment.
-end-


European Society for Medical Oncology

Related Tumor Articles from Brightsurf:

New cancer diagnostics: A glimpse into the tumor in 3D
A new technique could initiate a revolution in pathology: Tumor tissue is made transparent and illuminated with a special ultramicroscope.

Tumor progression depends on the tumor microenvironment
Researchers from Tokyo Medical and Dental University (TMDU) and Niigata University identified a novel mechanism by which tumors progress.

How do tumor cells divide in the crowd?
Scientists led by Dr. Elisabeth Fischer-Friedrich, group leader at the Excellence Cluster Physics of Life (PoL) and the Biotechnology Center TU Dresden (BIOTEC) studied how cancer cells are able to divide in a crowded tumor tissue and connected it to the hallmark of cancer progression and metastasis, the epithelial-mesenchymal transition (EMT).

Finding a way to STING tumor growth
The immune protein STING has long been noted for helping protect against viruses and tumors by signaling a well-known immune molecule.

Assembly within the tumor center
Number of macrophages in tumor tissue enables prognosis of lung tumor progression.

Mirror image tumor treatment
Our immune system ought to be able to recognize and kill tumor cells.

Traces of immortality in tumor DNA
To gain an infinite lifespan, cancer cells need to maintain the ends of their chromosomes, known as telomeres.

Peering into the genome of brain tumor
Scientists at Osaka University have created a machine learning method for classifying the mutations of glioma brain tumors based on MR images alone.

Glutamine-blocking drug slows tumor growth and strengthens anti-tumor response
A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.

Cancer genes and the tumor milieu
In a recent study published in Cancer Research, researchers demonstrate the role of an oncogene in altering the immediate environment of tumors.

Read More: Tumor News and Tumor Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.